We are live on ! Find out more
OCRX

Ocera Therapeutics, Inc.
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

41 hedge funds and large institutions have $46M invested in Ocera Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 3

34% more capital invested

Capital invested by funds: $34.4M → $46M (+$11.6M)

32% more funds holding

Funds holding: 31 → 41 (+10)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
41
Holders Change
+10
Holders Change %
+32.26%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
8
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$2.52M
2
GPP
Great Point Partners
Connecticut
+$611K
3
SFM
Sphera Funds Management
Israel
+$585K
4
JP Morgan Chase
JP Morgan Chase
New York
+$365K
5
BCM
Bridgeway Capital Management
Texas
+$165K

Top Sellers

Rank Fund Capital Flow
1
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
California
-$1.09M
2
TI
Turner Investments
Pennsylvania
-$857K
3
QF
QVT Financial
New York
-$342K
4
Millennium Management
Millennium Management
New York
-$335K
5
DCM
DAFNA Capital Management
California
-$238K
Name Holding Trade Value Shares
Change 		Change in
Stake
GPP
1
Great Point Partners
Connecticut
$12.5M +$611K +104,463 +6%
VM
2
VHCP Management
New York
$4.48M – – –
DCM
3
DAFNA Capital Management
California
$4.04M -$238K -40,757 -6%
QF
4
QVT Financial
New York
$3.81M -$342K -58,500 -9%
DM
5
Deerfield Management
New York
$2.94M – – –
Millennium Management
6
Millennium Management
New York
$2.74M -$335K -57,276 -12%
SFM
7
Sphera Funds Management
Israel
$2.68M +$585K +100,000 +31%
RCM
8
RA Capital Management
Massachusetts
$2.66M – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.84M -$19.6K -3,352 -1%
ECM
10
Endurant Capital Management
California
$1.34M +$1.23M +210,279 New
WMSA
11
Weiss Multi-Strategy Advisers
New York
$1.34M – – –
GTC
12
Ghost Tree Capital
New York
$796K – – –
OPPM
13
Opus Point Partners Management
New York
$781K +$718K +122,673 New
PVI
14
Pura Vida Investments
New York
$478K +$439K +75,000 New
Westfield Capital Management
15
Westfield Capital Management
Massachusetts
$416K – – –
JP Morgan Chase
16
JP Morgan Chase
New York
$397K +$365K +62,351 New
TI
17
Turner Investments
Pennsylvania
$395K -$857K -146,540 -70%
Fidelity Investments
18
Fidelity Investments
Massachusetts
$369K – – –
AIS
19
AlphaOne Investment Services
Pennsylvania
$270K -$33.3K -5,700 -12%
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$203K -$2.92K -500 -2%
California Public Employees Retirement System
21
California Public Employees Retirement System
California
$196K – – –
BCM
22
Bridgeway Capital Management
Texas
$180K +$165K +28,260 New
BFA
23
BlackRock Fund Advisors
California
$171K +$11.3K +1,926 +8%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$161K +$21K +3,593 +17%
CS
25
Credit Suisse
Switzerland
$119K +$109K +18,671 New
1
2

OCRX Hedge Fund Activity: Q4 2014 in Review

41 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q4 2014, worth a combined $46M — up 34% from $34.4M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new OCRX positions and 3 closed out — a net gain of 12 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $2.52M. The largest seller was Pacific Alternative Asset Management Company (PAAMCO), exiting entirely with an estimated $1.09M sold.

  • 41 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q4 2014, up from 31 in Q3 2014.
  • Funds reported $46M of Ocera Therapeutics, Inc. stock for Q4 2014, up 34% quarter-over-quarter.
  • 15 funds opened new Ocera Therapeutics, Inc. positions in Q4 2014 and 3 closed out, a net change of +12 holders.
  • The largest Ocera Therapeutics, Inc. buyer in Q4 2014 was Sabby Management, an estimated $2.52M added.
  • The largest Ocera Therapeutics, Inc. seller in Q4 2014 was Pacific Alternative Asset Management Company (PAAMCO), an estimated $1.09M sold.

Based on aggregated 13F filings for Q4 2014.